DRUG NAME CLASSIFICATI MECHANISM INDICATION AND ADVERSE NURSING

ON OF ACTION CONTRAINDICATIO ECTSF RESPONSIBILIT

N Y
GENERIC Functional Binds to an Indication: CNS: BEFORE:
NAME: Class: enzyme on Treatmebnt Dizziness -Assess for
OMEPRAZOL Therapeutic: gastric duodenal Drowsiness vital signs
E Anti-ulcer parientalcells ulcers,pathologic Fatigue -assess and
agents in the presence hypersecretory Headache teach
BRAND of acidic gastric conditions,gastro Weakness significant
NAME: PH,preventing esophageal reflux others of the
PRILOSEC the final disease(GERD) CV: patient the
transport of Chest pain common side
DOSAGE: hydrogen ions Contraindication: effects of the
40g into the gastric Hypersensitivity GI: drug and to
lumen Abdominal report any
pain severe adverse
Acid effects.
regurgitation DURING:
Constipation -Perform 15
Diarrhea rights of
Flatulence medication
Nausea -Assess patient
Vomiting routinely for
epigastric or
abdominal
pain,and frank
or occult blood
for the emesis
or stools
-Monitor CBC
with
differential
periodically
during therapy
-Take tablet or
capsule with a
full glass of
water
AFTER:
-May cause
serum gastrin
concentrations
to increase
during first 1-2
weeks of
therapy.Levels
return to
normal after
 DRUG CLASSIFICATIO MECHANISM OF INDICATION & ADVERSE NURSING
NAME N ACTION CONTRAINDICATIO EFFECTS RESPONSIBILIT
N Y
GENERIC PHARMACOLO Tranexamic acid INDICATION: CNS: BEFORE:
NAME: GIC: competively Treatment of Dizziness -Check the
Tranexami Antifibrinolyti inhibits activation excessive bleeding doctor’s order
discontinuatio
c Acid c of plasminogen(via resulting from CV: -Observe
n of the
binding to the systemic or local Hypotensi 15 rights
omeprazole of
BRAND THERAPEUTIC: kringle hyperfibrinolysis on drug
-Report to
NAME: Hemostatic domain),thereby thromboe administration
physician if any
Erfa- Agent reducing CONTRAINDICATIO mbolism, -Do skin
allergic
tranexami conversion of N: thrombosi testing
reaction occur
c PREGNANCY plasminogen to -hypersensitivity s -Caution
-Document
GATEGORY plasmin(fibrinolysin -active patient
findingsto
DOSAGE: RISK: ), an enzyme that intravascular GI: avoid products
1gm B degrades fibrin clotting Diarrhea containing
FREQUEN clots,fibrinogen, -Acquired defective nausea, aspirin or
T: and other plasma color vision vomiting NSAIDs
IV proteins,including -subarachnoid DURING:
the procoagulant hemorrhage -Administer
factors V and VII the drug at
the right
dosage and
route in the
right time
-check the
patency of the
IV site and IV
line
AFTER:
-Advise
patient to take
medication
exactly as
directed
-unusual
change in
bleeding
pattern should
be reported to
the physician
CLASSIFICATIO MECHANIS INDICATION AND ADVERSE NURSING
-report severe
N M OF CONTRAINDICATIO EFFECT RESPONSIBILI
allergic
ACTION NS TY
reactions such
as rash, hives,
itching,
dyspnea,
tightness in
the chest,
swelling of the
mouth, face
lips, or tongue
-if the patient
missed dose,
let patient
take when
remembered ,
then take next
dose at leat 6
DRUG NAME
GENERIC Anti-infectives Inhibition INDICATION: CNS -Obtain
NAME: -third of bacteria -Serious UTI and Seizures specimen for
CEFTRAZIDI generation lower respiratory Headache culture and
ME cephalosporin tract infection,skin Dizziness sensitivity
BRAND that inhibit gynecologic, CNS Parethesia tests before
NAME: cell-wall infection giving first
CEPTAZ synthesis. CV dose. Therapy
Promoting CONTRAINDICATIO Phelibitis may begin
DOSAGE: osmotic N: Thrombophebi while awaiting
1 gm instability, -Contraindicated in tis results
usually patients
bactericidal hypersensitive to GI -For IM use
drugs or other Nausea inject deep
cephalosporins Vomiting into a large
-use cautiously in Diarrhea muscle, such
patients Abdominal as the gluteus
hypersensitive to cramps maximus or
penicillin because the side of the
of possibility of GU thigh
cross-sesitivity with Vaginitis
other beta-lactam
antibiotics HEMATOLOGIC
Agranulocytosi
s
 DRUG CLASSIFICATIO MECHANISM INDICATION & ADVERSE NURSING
STUDY N OF ACTION CONTRAINDICATIO EFFECTS RESPONSIBILIT
N Y
GENERIC Opioid Tramadol acts INDICATION: -sweating -determine
NAME: analgesic as a opioid -relief of moderate -dizziness patients past
TRAMADO receptor to moderately -nausea or present
L agonist, severe pain -dry mouth history of
serotonin -fatigue addiction to or
releasing agent, CONTRAINDICATIO constipatio dependence
BRAND norephinephrin N: n on opioids
NAME: e reuptake -hypersensitivity to -instruct
ULTRAM inhibitor, NMDA the drug patient to
receptor -raised intracranial increase fluid
DOSAGE: antagonist 5- pressure intake to
50 mg HT2c receptor -severe renal prevent dry
antagonist, impairment mouth and
(a7)5 nicotinic constipation
acetylcholine -for better
receptor analgesic
antagonist effect, give
TRPPV1 drugs before
receptor onset of
agonist, and M1 intense pain.
and M3 mu -reassess level
scarinic of pain at least
acetylcholine 30 minutes
receptor after
antagonist administration
-Monitor CV
and respiratory
status.With
hold dose and
notify
precriber if
respirations
decrease or
rate is below
12
breaths/minut
e
DRUG NAME CLASSIFICATI MECHANISM OF INDICATION AND ADVERS NURSING
ON ACTION CONTRAINDICATIO E EFFECT RESPONSIBILI
N TY
GENERIC ANTIHISTAMI Diphenhydramine INDICATION General: -Assess for
NAME: NE acts as an inverse Temporarily Urticaria possible
DIPHENHYDR agonist at the H1 relieves these ,drug contraindicati
AMINE receptor, thereby symptoms due to rash,ana ons or
reversing effects of the common cold: phylactic cautions.
BRAND histamine on -runny nose shock,ph -Assess the
NAME: capillaries, reducing -sneezing otosensi skin color,
BENADRYL allergic reaction tivity, texture, and
symptoms. Lastly CONTRAINDICATIO excessiv lesions to
DOSAGE:2 diphenhydramine N: e monitor for
amp acts as an perspira anticholinergic
intracellular sodium tion,chill effects or
channel blocker, s,drynes allergy.
resulting in local s of Evaluate renal
anesthetic mouth,n and liver
properties ose, and function tests
throat to monitor for
factors that
Cardiova could affect
scular the
system metabolism or
:Hypote excretion of
nsion, the drug.
headach
e,
palpitati
ons,
tachycar
dia,extra
systoles

Hematol
ogic
System:
Hemolyti
c
anemia,t
hromboc
ytopenia
,agranul
ocytosis

Nervous
System:
Sedation
,sleepine
ss,dizzin
ess,distu
rbed
coordina
tion,fatig
ue,
confusio
n,restles
sness,ex
citation,
nervous
ness,tre
mor,irrit
ability
 DRUG CLASSIFICATION MECHANISM OF INDICATION AND ADVERSE NURSING
NAME ACTION CONTRAINDICATIO EFFECTS ReSPONSIBI
N LITY

GENERIC ANALGESICS(NO Antipyretic: INDICATION: CNS:heada -Do not

NAME: NOPIOID)ANTIP che exceed the
Reduces fever by Temporary
YRETIC recommen
PARACETAM acting directly on reduction of CV:chest
ded dosage
OL the hypothalamic fever,temporary pain,
heat-regulating relief of minor dyspnea, -Reduce
BRAND
center to cause aches and pains myocardia dosage
NAME:
vasodilation and caused by common l damage with
TYLENOL sweating, which cold and influenza, when hepatic
helps dissipate heat headache, sore doses of 5 impaireme
DOSAGE: throat, toothache, 8g/day are nt.
350 mg backache, ingested
-Avoid
menstrual cramps daily for
using
several
CONTRAINDICATIO multiple
weeks or
N: preparation
when
s containing
-Contraindicated doses of
acetaminop
with allergy to 4g/day are
hen.Careful
acetaminophen ingested
ly check all
for 1 yr.
-Ue cautiously with OTC
impaired hepatic GI:hepatic products
function, chronic toxicity
-Give drug
alcoholism, and
with food if
pregnancy, failure,
GI upset
lactation jaundice
occurs
GU:acute
-
renal
Discontinue
failure,
drug if
renal
hypersensi
tubular
tivity
necrosis
reactions
HEMATOL occur
OGIC:
-Treatment
Methemo of overdose
globinemi Monitor
a- serum
cyanosis:h levels
emolytic regularly,
anemia- N-
hematuria acetylcystei
, anuria, ne should
neutropen be available
ia, as a specific
leukopeni antidote
a,
pancytope
nia,
thromboc
ytopenia,
hypoglyce
mia

HYPERSEN
SITIVITY:

Rash,
fever